Endeavor

Can Viruses Be Used to Treat Lung Cancer?

Oncolytic virus therapy stimulates immune system to target cancer cells

Can Adding Immunotherapy to Chemo Benefit More Cervical Cancer Patients?

Phase 3 trial results suggest adding pembrolizumab to chemotherapy improved survival for those with advanced or recurrent disease

Ramping Up the Immune System to Fight Breast Cancer

Clinical trial led by Moffitt evaluates combination immunotherapy for HER2 positive metastatic disease

Treatment Innovations in Rectal, Lung and Brain Cancers

New research shows benefit of de-escalating and targeting therapies to improve outcomes

Comparing Therapy Options for Melanoma In-Transit Metastases

New retrospective study is first direct comparison of first-line treatment

Adding Inhibitor to Hormonal Therapy Reduces Risk of Breast Cancer Recurrence

Phase 3 trial results could be practice changing for both men and women

Mammograms and Pregnancy: What You Need To Know

Here’s when new moms should have breast cancer screenings

Moffitt Scientists Share Innovative Clinical Research at ASCO

The American Society of Clinical Oncology Annual Meeting attracts more than 40,000

Predicting Response to Herpes Virus in Triple-Negative Breast Cancer Patients

New study identifies genetic biomarkers that correlate with higher response rates